GW25-e4290 Efficacy and Safety of limus-eluting stent versus paclitaxel-eluting stent in patients with diabetes mellitus undergoing percutaneous coronary intervention: A meta-analysis

Meta Analysis ◽

Coronary Intervention ◽

Efficacy And Safety ◽

Percutaneous Coronary ◽

Efficacy and safety of bivalirudin versus heparin in patients with diabetes mellitus undergoing percutaneous coronary intervention

Medicine ◽

10.1097/md.0000000000007204 ◽

2017 ◽

Vol 96 (29) ◽

pp. e7204 ◽

Cited By ~ 1

Author(s):

Juan Zhang ◽

Xinchun Yang

Keyword(s):

Diabetes Mellitus ◽

Coronary Intervention ◽

Efficacy And Safety ◽

Percutaneous Coronary ◽

Paclitaxel-eluting stents versus sirolimus-eluting stents in patients with diabetes mellitus undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

Internal and Emergency Medicine ◽

10.1007/s11739-016-1529-0 ◽

2016 ◽

Vol 11 (7) ◽

pp. 1005-1013 ◽

Cited By ~ 3

Author(s):

Hui-bo Wang ◽

Ping Zeng ◽

Jun Yang ◽

Jian Yang ◽

Xiao-wen Liu

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Coronary Intervention ◽

Controlled Trials ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

American Journal of Cardiovascular Drugs ◽

10.1007/s40256-015-0113-8 ◽

2015 ◽

Vol 15 (4) ◽

pp. 275-285 ◽

Cited By ~ 7

Author(s):

Uzoma N. Ibebuogu ◽

Oluwaseyi Bolorunduro ◽

Smith Giri ◽

Sam Dagogo-Jack ◽

Blake G. Smith ◽

...

Keyword(s):

Diabetes Mellitus ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Coronary Intervention ◽

Controlled Trials ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies

BMC Cardiovascular Disorders ◽

10.1186/s12872-016-0343-y ◽

2016 ◽

Vol 16 (1) ◽

Cited By ~ 7

Author(s):

Pravesh Kumar Bundhun ◽

Chandra Mouli Yanamala ◽

Feng Huang

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Meta Analysis ◽

Coronary Intervention ◽

Anti Platelet Therapy ◽

Percutaneous Coronary ◽

Prolonged Duration ◽

Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

American Journal of Cardiovascular Drugs ◽

10.1007/s40256-015-0118-3 ◽

2015 ◽

Vol 15 (4) ◽

pp. 287-287

Author(s):

Uzoma N. Ibebuogu ◽

Oluwaseyi Bolorunduro ◽

Smith Giri ◽

Sam Dagogo-Jack ◽

Blake G. Smith ◽

...

Keyword(s):

Diabetes Mellitus ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Coronary Intervention ◽

Controlled Trials ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Successful percutaneous coronary intervention for acute myocardial infarction caused by simultaneous occlusion of two major coronary arteries in patients with diabetes mellitus

Acta Cardiologica ◽

10.2143/ac.60.2.2005037 ◽

2005 ◽

Vol 60 (2) ◽

pp. 225-228 ◽

Cited By ~ 8

Author(s):

Yasumasa IKEDA ◽

Hiroyuki FUJINAGA ◽

Toshiharu NIKI

Keyword(s):

Diabetes Mellitus ◽

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Coronary Arteries ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Ticagrelor Versus Prasugrel for the Treatment of Patients with Type 2 Diabetes Mellitus Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Diabetes Therapy ◽

10.1007/s13300-018-0537-7 ◽

2018 ◽

Vol 10 (1) ◽

pp. 81-93 ◽

Cited By ~ 4

Author(s):

Hua Yang ◽

Bing Tang ◽

Chen Hong Xu ◽

Anis Ahmed

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Coronary Intervention ◽

Percutaneous Coronary

IMPACT OF CHRONIC KIDNEY DISEASE ON CLINICAL OUTCOMES IN PATIENTS WITH DIABETES MELLITUS UNDERWENT PERCUTANEOUS CORONARY INTERVENTION USING DRUG-ELUTING STENT

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(15)61829-0 ◽

2015 ◽

Vol 65 (10) ◽

pp. A1829

Author(s):

Young Jin Youn ◽

Su-Min Kim ◽

Ji Hyun Lee ◽

Jun-Won Lee ◽

Sung-Gyun Ahn ◽

...

Keyword(s):

Diabetes Mellitus ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Clinical Outcomes ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Percutaneous Coronary ◽

Patients With Diabetes ◽

Drug Eluting

Gradient of Outcomes by Treatment Intensity in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention

Heart Lung and Circulation ◽

10.1016/j.hlc.2019.06.626 ◽

2019 ◽

Vol 28 ◽

pp. S401-S402

Author(s):

S. Biswas ◽

D. Dinh ◽

J. Lefkovits ◽

A. Ajani ◽

S. Duffy ◽

...

Keyword(s):

Diabetes Mellitus ◽

Coronary Intervention ◽

Treatment Intensity ◽

Percutaneous Coronary ◽

Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus

The American Journal of Cardiology ◽

10.1016/j.amjcard.2020.11.043 ◽

2020 ◽

Author(s):

Hao-Yu Wang ◽

Zhong-Xing Cai ◽

Dong Yin ◽

Yue-Jin Yang ◽

Wei-Hua Song ◽

...

Keyword(s):

Diabetes Mellitus ◽

High Risk ◽

Antiplatelet Therapy ◽

Dual Antiplatelet Therapy ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Prolonged Duration ◽

Patients With Diabetes ◽

Risk Patients